2.70
price down icon0.74%   -0.02
after-market Dopo l'orario di chiusura: 2.67 -0.03 -1.11%
loading

Aerovate Therapeutics Inc Azioni (AVTE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
11.57%
24.62
22.07 21.37 20.34 17.64
Operating Income/Loss
11.57%
-24.62
-22.07 -21.37 -20.34 -17.64
Income/Loss From Continuing Operations Before Tax
13.90%
-23.19
-20.36 -19.56 -19.02 -16.52
Income/Loss From Continuing Operations After Tax
13.58%
-23.19
-20.41 -19.56 -19.02 -16.52
Net Income/Loss
13.58%
-23.19
-20.41 -19.56 -19.02 -16.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,949%
27.80
0.4595 27.64 25.17 24.78
Diluted Average Shares
5,949%
27.80
0.4595 27.64 25.17 24.78
Basic Earnings Per Share
12.16%
-0.83
-0.74 -0.71 -0.76 -0.67
Diluted Earnings Per Share
12.16%
-0.83
-0.74 -0.71 -0.76 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):